Saturday, March 2, 2019

Top 5 Medical Stocks To Invest In 2019

tags:DPG,MNK,VMO,TEN,SAR, LISTEN TO ARTICLE 1:50 SHARE THIS ARTICLE Facebook Twitter LinkedIn Email

Hopelessly divided over Brexit, Prime Minister Theresa May’s Conservatives are now also publicly arguing about the merits of legalizing marijuana for medical use.

On the eve of a key vote that could deliver May a humiliating loss in Parliament, the government is struggling to show unity on any number of issues, from how to fund a boost to the National Health Service to whether to review its approach to medicinal cannabis.

Top 5 Medical Stocks To Invest In 2019: Duff & Phelps Global Utility Income Fund Inc.(DPG)

Advisors' Opinion:
  • [By Shane Hupp]

    Media headlines about Duff and Phelps Global Utlity Inm Fd (NYSE:DPG) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Duff and Phelps Global Utlity Inm Fd earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned media coverage about the investment management company an impact score of 48.1454031211079 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 5 Medical Stocks To Invest In 2019: Mallinckrodt plc(MNK)

Advisors' Opinion:
  • [By Sean Williams]

    After running a screen for healthcare stocks with a PEG ratio below 1 (courtesy of Yahoo! Finance), the following 13 were all that remained:

    Innoviva (NASDAQ:INVA): 0.42 PEG ratio Celgene (NASDAQ:CELG): 0.54 Mallinckrodt (NYSE:MNK): 0.59 Exelixis (NASDAQ:EXEL): 0.60 Global Cord Blood Corp.: 0.72 AbbVie: 0.75 Vertex Pharmaceuticals: 0.80 DaVita: 0.80 Supernus Pharmaceuticals: 0.80 Mednax: 0.82 MiMedx Group: 0.88 CIGNA: 0.93 Medpace Holdings: 0.95

    Image source: Getty Images.

  • [By Lisa Levin] Companies Reporting Before The Bell Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion. Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion. Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion. Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion. Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million. The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion. Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion. US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion. DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion. Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million. Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion. Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion. Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion. JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Paul Ausick]

    Mallinckrodt plc (NYSE: MNK) fell by more than 10% Thursday to post a new 52-week low of $13.32 after closing at $14.90 on Wednesday. The 52-week high is $49.12. Volume of about 7.6 million was about double the daily average. The company has been hit with a whistleblower lawsuit related to its best-selling drug.

  • [By Joseph Griffin]

    Mallinckrodt (NYSE:MNK) was downgraded by research analysts at Goldman Sachs Group to a “sell” rating in a note issued to investors on Tuesday. They currently have a $28.00 target price on the stock. Goldman Sachs Group’s price target would suggest a potential downside of 15.15% from the stock’s previous close.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Mallinckrodt (MNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Canaccord Genuity set a $34.00 price objective on Mallinckrodt (NYSE:MNK) in a research report released on Sunday. The firm currently has a hold rating on the stock.

Top 5 Medical Stocks To Invest In 2019: Invesco Municipal Opportunity Trust(VMO)

Advisors' Opinion:
  • [By Logan Wallace]

    Invesco Van Kampen Municpl Opprtnty Trst (NYSE:VMO) declared a monthly dividend on Tuesday, April 3rd, Wall Street Journal reports. Shareholders of record on Tuesday, April 17th will be paid a dividend of 0.0554 per share by the investment management company on Monday, April 30th. This represents a $0.66 dividend on an annualized basis and a dividend yield of 5.66%. The ex-dividend date of this dividend is Monday, April 16th.

Top 5 Medical Stocks To Invest In 2019: Tenneco Inc.(TEN)

Advisors' Opinion:
  • [By Logan Wallace]

    Gentex (NASDAQ: GNTX) and Tenneco (NYSE:TEN) are both mid-cap auto/tires/trucks companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, risk, earnings and dividends.

  • [By Max Byerly]

    Tokenomy (CURRENCY:TEN) traded up 1.7% against the dollar during the twenty-four hour period ending at 10:00 AM ET on August 10th. Tokenomy has a market capitalization of $36.73 million and approximately $881,640.00 worth of Tokenomy was traded on exchanges in the last day. One Tokenomy token can currently be purchased for approximately $0.18 or 0.00002849 BTC on major exchanges including Indodax, CoinBene, Tokenomy and LATOKEN. Over the last week, Tokenomy has traded 7.1% lower against the dollar.

  • [By Logan Wallace]

    Tenneco Inc (NYSE:TEN) was up 5.1% during trading on Thursday . The stock traded as high as $46.51 and last traded at $46.32. Approximately 559,060 shares changed hands during trading, a decline of 0% from the average daily volume of 560,710 shares. The stock had previously closed at $44.06.

Top 5 Medical Stocks To Invest In 2019: Saratoga Investment Corp(SAR)

Advisors' Opinion:
  • [By Shane Hupp]

    Media stories about Saratoga Investment (NYSE:SAR) have trended somewhat positive on Friday, Accern Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Saratoga Investment earned a daily sentiment score of 0.07 on Accern’s scale. Accern also assigned press coverage about the financial services provider an impact score of 45.7589775169552 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

  • [By Max Byerly]

    Headlines about Saratoga Investment (NYSE:SAR) have been trending somewhat positive this week, according to Accern Sentiment. Accern rates the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Saratoga Investment earned a daily sentiment score of 0.17 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 45.4912059514825 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    Shares of Saratoga Investment Corp (NYSE:SAR) reached a new 52-week high and low on Friday after an insider bought additional shares in the company. The stock traded as low as $22.95 and last traded at $22.85, with a volume of 650 shares. The stock had previously closed at $22.70.

  • [By Logan Wallace]

    ValuEngine downgraded shares of Saratoga Investment (NYSE:SAR) from a buy rating to a hold rating in a research report released on Wednesday.

    A number of other analysts have also issued reports on the stock. National Securities reiterated a neutral rating and set a $24.00 price target (up from $23.00) on shares of Saratoga Investment in a research note on Friday, January 12th. Zacks Investment Research lowered shares of Saratoga Investment from a hold rating to a sell rating in a research note on Friday, March 2nd. Finally, B. Riley initiated coverage on shares of Saratoga Investment in a research note on Tuesday, March 27th. They set a buy rating and a $23.50 price target on the stock. Four investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Saratoga Investment presently has a consensus rating of Buy and an average price target of $24.38.

  • [By Stephan Byrd]

    Saratoga Investment Corp (NYSE:SAR) – Equities research analysts at B. Riley dropped their Q3 2019 EPS estimates for shares of Saratoga Investment in a report issued on Thursday, August 23rd. B. Riley analyst T. Hayes now forecasts that the financial services provider will post earnings of $0.54 per share for the quarter, down from their prior forecast of $0.55. B. Riley also issued estimates for Saratoga Investment’s Q2 2020 earnings at $0.58 EPS.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Saratoga Investment (SAR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

1 comment: